These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20860991)

  • 1. Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.
    Price TJ; Townsend AR; Khattak A
    Ann Oncol; 2010 Oct; 21(10):2121; author reply 2121-2. PubMed ID: 20860991
    [No Abstract]   [Full Text] [Related]  

  • 2. Capecitabine in combination with irinotecan or oxaliplatin in advanced colorectal cancer.
    Clin Colorectal Cancer; 2003 Aug; 3(2):89-91. PubMed ID: 12952563
    [No Abstract]   [Full Text] [Related]  

  • 3. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
    Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of capecitabine in the treatment of colorectal cancer.
    Rothenberg ML
    Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study.
    Rosati G; Cordio S; Bordonaro R; Caputo G; Novello G; Reggiardo G; Manzione L
    Ann Oncol; 2010 Apr; 21(4):781-786. PubMed ID: 19713248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine combinations in the treatment of advanced colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Nov; 1(3):146-8. PubMed ID: 12450426
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.
    Koopman M; Antonini NF; Douma J; Wals J; Honkoop AH; Erdkamp FL; de Jong RS; Rodenburg CJ; Vreugdenhil G; Akkermans-Vogelaar JM; Punt CJ
    Ann Oncol; 2006 Oct; 17(10):1523-8. PubMed ID: 16873425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer.
    Shin SJ; Ahn JB; Choi HJ; Cho BC; Jeung HC; Rha SY; Chung HC; Roh JK
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):75-81. PubMed ID: 17375304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.
    Koopman M; Antonini NF; Douma J; Wals J; Honkoop AH; Erdkamp FL; de Jong RS; Rodenburg CJ; Vreugdenhil G; Loosveld OJ; van Bochove A; Sinnige HA; Creemers GM; Tesselaar ME; Slee PHTJ; Werter MJ; Mol L; Dalesio O; Punt CJ
    Lancet; 2007 Jul; 370(9582):135-142. PubMed ID: 17630036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New studies highlight benefit of Xeloda in new combination treatments for colorectal cancer.
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):241-2. PubMed ID: 12113038
    [No Abstract]   [Full Text] [Related]  

  • 11. Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy.
    Varadhachary GR; Hoff PM
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S40-2. PubMed ID: 16399430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killing.
    Goldberg RM
    Onkologie; 2010; 33(6):291-2. PubMed ID: 20523091
    [No Abstract]   [Full Text] [Related]  

  • 13. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365
    [No Abstract]   [Full Text] [Related]  

  • 14. Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?
    Schmoll HJ; Sargent D
    Lancet; 2007 Jul; 370(9582):105-107. PubMed ID: 17630019
    [No Abstract]   [Full Text] [Related]  

  • 15. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
    Moosmann N; Heinemann V
    Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?
    Aguado C; García-Paredes B; Sotelo MJ; Sastre J; Díaz-Rubio E
    World J Gastroenterol; 2014 May; 20(20):6092-101. PubMed ID: 24876731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer: chemotherapy treatment overview.
    Royce ME; Medgyesy D; Zukowski TH; Dwivedy S; Hoff PM; Pazdur R
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):40-6. PubMed ID: 11200148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Capecitabine and irinotecan].
    Gasperoni S
    Suppl Tumori; 2004; 3(4):S107-8. PubMed ID: 15206231
    [No Abstract]   [Full Text] [Related]  

  • 20. Current and ongoing trials with irinotecan in the United States.
    Fuchs CS
    Semin Oncol; 2003 Aug; 30(4 Suppl 12):9-17. PubMed ID: 14508722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.